MikeTrendsTrends right now
AI: reposAPI

search

Tagrisso

Trends

  1. 1
    Hansoh lung cancer drug loses EU approval after AstraZeneca challenge▼Hansoh’s Tagrisso rival loses EU approval after AstraZeneca legal challenge✉newsWorldEU Politics47 min ago

    A copy of AstraZeneca's lung cancer drug Tagrisso developed by China's Hansoh Pharmaceutical has lost its European Union approval following a legal challenge mounted by AstraZeneca. The ruling removes the competing medicine from the EU market for now and hands the British drugmaker a win in its defence of Tagrisso's franchise, one of its biggest oncology products.